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ORIGINAL ARTICLE
Clinic-based biopsy with a small curette: is it a reliable and safe option in
extremity tumours?
Waseem Ahmed, Masood Umer, Yasir Mohib, Rizwan Haroon Rashid

Abstract
Objective: To establish the diagnostic accuracy and safety of clinic-based biopsy done with a small curette.
Methods: The retrospective study was conducted at Aga Khan University Hospital Karachi and comprised data of
patients who underwent biopsy procedure of extremity tumours in clinic under local anaesthesia from July 2009 to
June 2012. Patients who underwent the procedure in operating room under general anaesthesia were excluded and
so were those with insufficient or missing information, or those who had the final procedure done elsewhere.
Clinical parameters were evaluated and histo-pathology was compared with the final resected specimen.
Results: The mean age of the 51 patients in the study was 32±19.6 years. Lower extremity was involved in 37(73%)
cases, and the most common tumour was osteosarcoma in 9(17%).Biopsy was inconclusive in 2(4%) patients,
leaving the clinical accuracy to be 94%. The cost of clinic-based biopsy was at least seven times less than those done
in the operating room under general anaesthesia.
Conclusion: Biopsy done in a clinic with a small curette is accurate, safe and cost-effective method.
Keywords: Biopsy, Histopathology, Clinic biopsy, Curette. (JPMA 65: S-205 (Suppl. 3); 2015)

Introduction
The biopsy is a critical step in the diagnosis of neoplastic,
inflammatory, infectious and reactive lesions of the
musculoskeletal system. Open, incisional biopsy is
traditionally considered to be the gold standard, but it
needs to be done in the operating room (OR) under
general anaesthesia. The overall diagnostic accuracy of
open biopsies ranges from 91% to 96%.1 Complications of
this procedure includes seroma, hematoma, infection,
wound dehiscence with tumour seeding the biopsy tract
and fracture, and it tends to occur more frequently after
open or excisional biopsies. The complication rate of
percutaneous techniques ranges from 0% to 1% and of
surgical open biopsies from 4% to 19%.2
As an alternative to open biopsy, percutaneous
techniques, including core needle biopsy (CNB) and
curette biopsy, have been developed. These techniques
can be performed in clinic under local anaesthesia when
the lesion or pertinent landmarks are palpable or in the
radiology suite using fluoroscopy,
computed
tomography (CT), magnetic resonance imaging (MRI), or
ultrasound (US).3 Advantages of clinic-based biopsyover
open or image-assisted biopsies include decreased cost,
unnecessary scheduling delays, lower complication rates,
and smaller incisions that may be easier to incorporate
into the definitive surgical resection.4 Problems with
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needle biopsy may include insufficient samples with
inconclusive results, which ultimately leads to a second
procedure of open biopsies preferably in OR, further
adding to the financial burden.5
Based on all these issues, including the financial burden
on the poor patient undergoing these investigations as
well as interventions in the form of neoadjuvant therapy,
surgeries and adjuvant therapies, clinic-based biopsy is a
safe and cost-effective method confirming the diagnosis.6
The current study was planned to establish the diagnostic
accuracy and safety of clinic-based biopsies done with a
small curette.

Material and Methods
The retrospective study was conducted at Aga Khan
University Hospital and comprised data of patients who
underwent biopsy procedure of extremity tumours in
clinic under local anaesthesia from July 2009 to June
2012. Patients who underwent the procedure in operating
room under general anaesthesia were excluded and so
were those with insufficient or missing information, or
those who had the final procedure done elsewhere.
All biopsies had been performed by consultant
orthopaedic oncologists, using 2% of lidocaine solution
for local anaesthesia infiltration. Stab incision with No.11
blade was used to incise the skin and to breach fascia.
Then curette was advanced to get the final specimen.
Multiple specimens were obtained using the same
incision. Specimens were processed routinely for
Vol. 65, No.11 (Suppl. 3), November 2015

S-206
histopathology and immuno-histo-chemical studies were
performed at the discretion of the interpreting
pathologist. Clinical parameters in terms of age, gender,
site and tissue involvement, grade of lesion, and
complications were noted. Clinical histopathology was
compared with the final resected specimen.

Results
A total of 120 medical records were reviewed, but 53(44%)
patients who had undergone the procedure in OR under
general anaesthesia were excluded. Another 16(13) had to
be excluded as they had either insufficient or missing
information or had their final procedure done elsewhere.
The final study sample, as such, stood at 51(42.5%).
The median age of the sample was 29 years (range: 16-58
years). There were 27(53%) males and 24(47%) were
females. Lower extremity was involved in 37(73%) and the
upper extremityin 14(27%) patients. Overall, 37(72%)
were malignant and 14(28%) were benign lesions. In
35(69%) cases, lesion was arising from soft tissues and
16(31%) patients had the lesion arising from bone. The
most common tumour was osteosarcoma in 9(17%)
followed by Ewings in 8(15%), synovial sarcoma in 7(14%)
and spindle sarcoma in 3(7%). The rest of the tumours
includedmalignant fibrous histiocytoma (MFH),
chondrosarcoma, liposarcoma etc.
Biopsy was inconclusive in 2(4%) patients, leaving the
clinical accuracy to be 94%. These patients then
underwent re-biopsy in OR but histo-pathological
diagnosis of 1(2%) patient could not be established.
The only complications encountered were surgical-site
infection in 2(4%) patients which was managed
successfully with antibiotics.

Discussion
The optimal technique for the biopsy of malignant
neoplasms of soft tissue and bone remains controversial
and is often dictated by the preference of the operating
surgeon.7 Although curette biopsy has been more widely
used in recent years, but the literature for diagnostic yield
and accuracy remains quite variable.8
Skrzynski et al.5 prospectively analysed 62 patients
undergoing outpatient CNB and reported an overall
diagnostic accuracy of 84%, with 13% biopsies considered
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non-diagnostic, compared with 96% accuracy in a
contemporary cohort of patients undergoing open
biopsy. In a series of CNB, Heslin et al.9 obtained adequate
biopsy samples in 93% and established a correct
diagnosis of malignancy in 95%, histology in 75%, and
grade in 88%, and the results were comparable to their
open biopsy results for malignancy and grade. In an
analysis by Ball et al.10 of 52 CNBs, the overall accuracy was
98%, but inadequate or non-diagnostic biopsy specimens
were excluded from statistical analysis.
In our study, clinic-based biopsies showed a 94% accuracy
rate for malignancy and was diagnostic and accurate for
histopathological diagnosis. Our findings, thus, are
consistent with the aforementioned results of clinic-based
biopsies.

Conclusion
Clinic-based curette biopsy is a cost-effective and
accurate method of diagnosis with negligible
complication rates in the hands of trained orthopaedic
oncologists.
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